TOKYO, May 12 -- Ministry of Foreign Affairs of Japan issued the following news release: On May 11, 2026, Mr. HORII Iwao, State Minister for Foreign Affairs, attended the Reception of Celebration of ... Read More
TOKYO, May 12 -- Prime Minister and His Cabinet issued the following information: [Provisional translation] On May 12, 2026, Prime Minister Takaichi received a courtesy call from the Honorable Scott... Read More
Tokyo, May 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061540) titled 'A Retrospective Study of the Relationship Between Chest Tube Placement and P... Read More
Tokyo, May 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061539) titled 'A Survey of Satisfaction with Anma Massage and Shiatsu (Finger Pressure Ther... Read More
Tokyo, May 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061536) titled 'The Effectiveness of Smartphone Apps in Improving Mothers'Mental Health and ... Read More
Tokyo, May 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061535) titled 'Machine learning using combined positron emission tomography and computed to... Read More
Tokyo, May 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061533) titled 'Effective Implementation of The Evidence-Based Specific Health Guidance' on ... Read More
Tokyo, May 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061529) titled 'A retrospective survey of FLEND therapy for relapsed or refractory T-cell ac... Read More
Tokyo, May 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061527) titled 'Study evaluating the introduction of the Maternal and Child Health Handbook ... Read More
Tokyo, May 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061522) titled 'Long-Term Follow-Up Analysis of a Phase II Study of Durvalumab Plus Concurre... Read More